ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets

RTTNews | 916日前
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.

ANI's Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.

The current annual U.S. market for Clorazepate Dipotassium Tablets is approximately $25.8 million, according to IQVIA/IMS Health, a leading healthcare data and analytics provider.

read more
Japan Leading Index Data Due On Wednesday

Japan Leading Index Data Due On Wednesday

Japan will on Wednesday see October results for its leading and coincident indexes, highlighting a light day for Asia-Pacific economic activity.
RTTNews | 10時59分前
TSX Ends Shortened Session On Firm Note

TSX Ends Shortened Session On Firm Note

The Canadian market ended the shortened trading session on Tuesday modestly higher thanks to gains in energy and technology sectors. The volume of business remained rather thin as investors refrained from making significant moves ahead of Christmas and Boxing Day holidays.
RTTNews | 15時17分前
Pound Climbs Against Majors

Pound Climbs Against Majors

The pound rose against its major counterparts in the New York session on Tuesday.
RTTNews | 17時38分前